Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 5/20 | 0.36 |
| ▸ | PPARA | Q07869 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.34 |
| ▸ | TDP2 | O95551 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20911036 | 0.93 | PPARG (0.36) | MAT2APPARGPPARAATMABCG2 | |
| SCHEMBL21090334 | 0.93 | MAT2A (0.40) | MAT2APPARGPPARAKDM4EATM | |
| SCHEMBL20911035 | 0.92 | KIF11 (0.36) | MAT2APPARGPPARAATMABCG2 | |
| SCHEMBL20902598 | 0.91 | PPARG (0.35) | MAT2APPARGPPARAATMABCG2 | |
| SCHEMBL20910723 | 0.90 | PPARG (0.34) | PPARGPPARAATMABCG2LMNA | |
| SCHEMBL20910652 | 0.90 | MAT2A (0.38) | MAT2APPARGPPARAKDM4EATM | |
| SCHEMBL20902585 | 0.90 | MAT2A (0.39) | MAT2APPARGPPARAKDM4EATM | |
| SCHEMBL21090335 | 0.90 | MAT2A (0.40) | MAT2APPARGPPARAKDM4EATM | |
| SCHEMBL20910897 | 0.90 | LMNA (0.37) | MAT2APPARGPPARAABCG2TDP2 | |
| SCHEMBL20910722 | 0.89 | PPARG (0.35) | MAT2APPARGPPARAABCG2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10998504-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-05-04 | — | — | US | disclosed |
| US-20190115544-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10998504-B2 | Organic molecules for use in optoelectronic devices | OCIAD1, OCIAD2, POU2F1 | MAT2A 2636/4885PPARG 651/4885PPARA 1252/4885 |
| US-20190115544-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OCIAD1, OCIAD2, POU2F1 | MAT2A 2636/4885PPARG 651/4885PPARA 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.